Products
Investing
Resources
Support
Concord Biotech Limited (CONCORDBIO)
₹1,557.8
INR-127.40(-7.56%)
As of April 29, 2025 9:59:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹17450.77 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹15963.24 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
51.59
Forward P/E
Price to Earnings ratio based on forecasted earnings
36.49
PEG Ratio
Price/Earnings to Growth ratio
1.82
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
16.02
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
78.54%
Operating Margin
Operating income as a percentage of revenue
34.68%
Return on Equity
Net income as a percentage of shareholders' equity
20.18%
Revenue (TTM)
Total revenue over trailing 12 months
₹1089.17 Cr+1.4000000000000001%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹494.10 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹30.44-2.1%
Balance Sheet
Total Cash
Total cash and short-term investments
₹283.74 Cr
Total Debt
Total short-term and long-term debt
₹3.42 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
0.21%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹1327.05 - ₹2664
Beta
Measure of stock's volatility compared to the market
NA
Shares Outstanding
Total number of shares issued by the company
₹10.46 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
0.55%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
NA
Payout Ratio
Percentage of earnings paid as dividends
28.05%